Cargando…
mTOR contributes to endothelium-dependent vasorelaxation by promoting eNOS expression and preventing eNOS uncoupling
Clinically used inhibitors of mammalian target of rapamycin (mTOR) negatively impacts endothelial-dependent vasodilatation (EDD) through unidentified mechanisms. Here we show that either the endothelium-specific deletion of Mtor to inhibit both mTOR complexes, or depletion of Raptor or Rictor to dis...
Autores principales: | Wang, Yiying, Li, Qiannan, Zhang, Zhiyang, Peng, Kai, Zhang, Dai-Min, Yang, Qianlu, Passerini, Anthony G., Simon, Scott I., Sun, ChongXiu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9307829/ https://www.ncbi.nlm.nih.gov/pubmed/35869262 http://dx.doi.org/10.1038/s42003-022-03653-w |
Ejemplares similares
-
Nafamostat mesilate promotes endothelium-dependent vasorelaxation via the Akt-eNOS dependent pathway
por: Choi, Sujeong, et al.
Publicado: (2016) -
Ursolic acid prevents doxorubicin‐induced cardiac toxicity in mice through eNOS activation and inhibition of eNOS uncoupling
por: Mu, Haiman, et al.
Publicado: (2019) -
Molecular mechanisms underlying pharmacological stimulation of eNOS expression and eNOS activity
por: Li, Huige, et al.
Publicado: (2009) -
Stachydrine protects eNOS uncoupling and ameliorates endothelial dysfunction induced by homocysteine
por: Xie, Xinya, et al.
Publicado: (2018) -
Arginase-I enhances vascular endothelial inflammation and senescence through eNOS-uncoupling
por: Zhu, Cuicui, et al.
Publicado: (2017)